Fmr LLC Rapt Therapeutics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 5,235,521 shares of RAPT stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,235,521

Previous 5,219,655 0.3%

Holding current value

$10.1 Million

Previous $46.9 Million 65.93%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.89 - $9.38 $45,852 - $148,823	15,866 Added 0.3%	5,235,521 $16 Million
Q1 2024 May 13, 2024	BUY	$6.87 - $26.45 $9.45 Million - $36.4 Million	1,376,268 Added 35.81%	5,219,655 $46.9 Million
Q4 2023 Feb 13, 2024	SELL	$11.28 - $25.46 $7.4 Million - $16.7 Million	-655,906 Reduced 14.58%	3,843,387 $95.5 Million
Q3 2023 Nov 13, 2023	BUY	$16.34 - $24.66 $5.05 Million - $7.62 Million	308,804 Added 7.37%	4,499,293 $74.8 Million
Q2 2023 Aug 11, 2023	SELL	$16.06 - $21.61 $4.26 Million - $5.73 Million	-265,351 Reduced 5.96%	4,190,489 $78.4 Million
Q1 2023 May 11, 2023	BUY	$17.19 - $30.8 $25.8 Million - $46.3 Million	1,503,626 Added 50.93%	4,455,840 $81.8 Million
Q4 2022 Feb 13, 2023	SELL	$16.28 - $24.6 $10.2 Million - $15.4 Million	-624,411 Reduced 17.46%	2,952,214 $58.5 Million
Q3 2022 Nov 10, 2022	SELL	$17.96 - $30.46 $9.33 Million - $15.8 Million	-519,541 Reduced 12.68%	3,576,625 $86.1 Million
Q2 2022 Aug 12, 2022	BUY	$10.26 - $23.59 $9.37 Million - $21.5 Million	913,465 Added 28.7%	4,096,166 $74.8 Million
Q1 2022 May 13, 2022	BUY	$17.02 - $40.22 $15.9 Million - $37.6 Million	933,868 Added 41.53%	3,182,701 $70 Million
Q4 2021 Feb 14, 2022	BUY	$29.5 - $39.5 $32.7 Million - $43.8 Million	1,107,704 Added 97.07%	2,248,833 $82.6 Million
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $34.1 Million - $45 Million	1,141,129 New	1,141,129 $35.4 Million

Others Institutions Holding RAPT

# of Institutions

125

Shares Held

29.1M

Call Options Held

905K

Put Options Held

592K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $57.2M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account